IonQ Announces Full Year 2021 Financial Results and Provides Business Update
IonQ reported strong financial results for 2021, with total contract bookings of $16.7 million, exceeding guidance by 5%. Fourth-quarter revenue reached $1.6 million, a 50% beat on expectations, contributing to a total annual revenue of $2.1 million (31% above forecasts). The company expects revenue in 2022 to quintuple to between $10.2 million and $10.7 million. IonQ also announced a significant commercial partnership with Hyundai to enhance electric vehicle battery technology and made strides in quantum computing by achieving record algorithmic qubits.
- Total contract bookings of $16.7 million, 5% above guidance.
- Fourth quarter revenue of $1.6 million, 50% above forecasts.
- Expected 2022 revenue growth of 5x from 2021, between $10.2 million and $10.7 million.
- Major commercial agreement with Hyundai for quantum algorithms in EV batteries.
- Significant advances in quantum computing technology, including 20 algorithmic qubits.
- Net loss of $106.2 million for 2021.
- Adjusted EBITDA loss anticipated at $55 million for 2022.
Total contract bookings of
Total contract bookings of
Increases total contract bookings guidance midpoint
—
Revenue of
Revenue of
Expects 2022 revenue to be 5x 2021’s topline
“IonQ’s 2021 was outstanding. We more than tripled our initial bookings target, announced what we believe to be the world’s most powerful quantum computer, and became the world’s first public quantum computing company,” said
2021 Financial Highlights
-
After tripling the Company’s original 2021 contract bookings forecast in September from
to$5 million ,$15 million IonQ beat that number again to end up at for the full year.$16.7 million -
IonQ achieved revenue of for the full year, which was$2.1 million 31% above the$1.6 million IonQ forecasted on the Company’s Q3 call. -
Cash, cash equivalents and investments were
as of$603 million December 31, 2021 . -
Net loss was
and adjusted EBITDA loss was$106.2 million for 2021.*$28.3 million
* Adjusted EBITDA is a non-GAAP financial measure defined under “Non-GAAP Financial Measures,” and is reconciled to net loss, its closest comparable GAAP measure, at the end of this release.
2022 Financial Outlook
-
IonQ expects revenue for 2022 to be 5x IonQ’s 2021 topline. For the full year 2022,IonQ expects revenue to be between and$10.2 million , with between$10.7 million and$1.8 million for the first quarter.$2.0 million -
IonQ anticipates full year 2022 bookings of between and$20 million , with between$24 million and$3 million for the first quarter.$4 million -
IonQ believes that over the next two years, one or two system sales could push combined TCV contract bookings over nine figures for the three year period from 2021 to 2023. -
IonQ anticipates an adjusted EBITDA loss of for the full year 2022 at the midpoint of the revenue outlook provided above.**$55 million
**The Company cannot provide a reconciliation between its forecasted Adjusted EBITDA and net loss without unreasonable effort due to the unavailability of estimates for stock-based compensation and change in fair value of assumed warrant liabilities as these items are not within the Company’s control, may vary greatly between periods and could significantly impact future financial results.
Commercial Highlights
- In January, the Company announced a major commercial deal with Hyundai Motor Company to develop quantum algorithms that may improve the charging, discharging, durability, capacity, and safety of electric vehicle batteries.
-
IonQ is collaborating withOak Ridge National Laboratory to research metal hydrides, which can benefit development of technologies including batteries and hydrogen storage for hydrogen powered vehicles. -
In 2021,
IonQ collaborated with leading organizations such as Accenture, Goldman Sachs, andGE Research . -
In 2021,
IonQ partnered withThe University of Maryland to create theNational Quantum Lab atMaryland (Q-Lab ), the nation’s first user facility to enable hands-on access to a commercial-grade quantum computer.
Technical Highlights
-
In February,
IonQ announced that the latest-generation IonQ Aria system achieved a record 20 algorithmic qubits, representing a massive leap forward not just forIonQ , but for the entire quantum computing industry. -
In March, Microsoft announced official plans to bring IonQ Aria to the Azure Quantum Cloud, democratizing access to the world’s most powerful quantum computer.
IonQ became the only company to make its quantum computers available via all three major cloud providers (Google Cloud, Microsoft Azure, AWS) in 2021. -
In December,
IonQ announced plans to build quantum computers with barium qubits, which the Company expects will contribute to higher gate fidelity, faster gates, lower error rates, and lower system costs. - IonQ’s new barium qubits are already delivering on their promise of more accurate quantum computing with recent results showing a 13-fold reduction in state preparation and measurement errors.
-
The Company has secured a sustainable, perpetual source of barium qubits through a partnership with the
U.S. Department of Energy’sPacific Northwest National Laboratory (PNNL). -
Earlier this year,
IonQ announced the invention of a new family of quantum gates in collaboration with the Duke Quantum Center (DQC) atDuke University .IonQ believes these new gates will eventually lead to more efficient quantum algorithms requiring many fewer qubits. Importantly, the gates can only be run using the unique architecture employed byIonQ and DQC systems. -
Last year,
IonQ became the first team in the world to demonstrate fault-tolerant error correction in practice, as documented in a peer-reviewed Nature paper in collaboration withDuke University , theUniversity of Maryland and theGeorgia Institute of Technology .
Team Highlights
-
IonQ hired world-class talent, with key positions filled byThomas Kramer as Chief Financial Officer (Opower , Cvent),Tom Jones asChief People Officer (Blue Origin, Microsoft, Honeywell),Laurie Babinski as General Counsel and Secretary (Intuit’s Credit Karma),Ariel Braunstein as Senior Vice President of Product Management (Google ,Lytro , Cisco),Dean Kassmann as Vice President of Research and Development (Blue Origin, Amazon),Jordan Shapiro as Vice President of Financial Planning & Analysis (NEA, Samsung),Kevin Caimi as Controller (Opower ,Ernst & Young ), Anant Sanchetee as Senior Director of Marketing (Meta, Dreem), andMark Solomon as Director of Quantum Sales (IBM). -
IonQ appointedInder Singh , CFO of Arm, as an independent member of the Company’s Board of Directors.
Fourth Quarter 2021 Conference Call
Non-GAAP Financial Measures
To supplement IonQ’s condensed financial statements presented in accordance with GAAP, we use non-GAAP measures of certain components of financial performance. Adjusted EBITDA is a financial measure that is not required by or presented in accordance with GAAP. Management believes that this measure provides investors an additional meaningful method to evaluate certain aspects of the company’s results period over period. Adjusted EBITDA is defined as net loss before interest expense, income tax expense (benefit), depreciation and amortization expense, stock-based compensation, remeasurements of liability-classified warrants, and other nonrecurring nonoperating income and expenses. We use Adjusted EBITDA to measure the operating performance of our business, excluding specifically identified items that we do not believe directly reflect our core operations and may not be indicative of our recurring operations. The presentation of non-GAAP financial measures is not meant to be considered in isolation or as a substitute for the financial results prepared in accordance with GAAP, and the Company’s non-GAAP measures may be different from non-GAAP measures used by other companies. For IonQ’s investors to be better able to compare its current results with those of previous periods, the Company has shown a reconciliation of GAAP to non-GAAP financial measures at the end of this release.
About
Forward-Looking Statements
This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Some of the forward-looking statements can be identified by the use of forward-looking words. Statements that are not historical in nature, including the words “anticipate,” “expect,” “suggests,” “plan,” “believe,” “intend,” “estimates,” “targets,” “projects,” “should,” “could,” “would,” “may,” “will,” “forecast” and other similar expressions are intended to identify forward-looking statements. These statements include those related to the Company’s ability to further develop and advance its quantum computers and achieve scale; ability to attract personnel; market opportunity, anticipated growth, and future financial performance, including management’s financial outlook for 2022. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to: management’s financial outlook for 2022; market adoption of quantum computing solutions and the Company’s products, services and solutions; the ability of the Company to protect its intellectual property; changes in the competitive industries in which the Company operates; changes in laws and regulations affecting the Company’s business; the Company’s ability to implement its business plans, forecasts and other expectations, and identify and realize additional partnerships and opportunities; and the risk of downturns in the market and the technology industry including, but not limited to, as a result of the COVID-19 pandemic. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” section of IonQ’s Quarterly Report on Form 10-Q for the quarter ended
|
|||||||||||||
Condensed Consolidated Statements of Operations |
|||||||||||||
(unaudited) |
|||||||||||||
(in thousands, except share and per share data) |
|||||||||||||
Three Months Ended |
|
Year Ended |
|||||||||||
|
|
|
|||||||||||
2021 |
2020 |
|
2021 |
2020 |
|||||||||
Revenue |
$ |
1,648 |
|
$ |
- |
|
$ |
2,099 |
|
$ |
- |
|
|
Costs and expenses: |
|||||||||||||
Cost of revenue (excluding depreciation and amortization) |
|
298 |
|
|
86 |
|
|
1,040 |
|
|
143 |
|
|
Research and development |
|
4,917 |
|
|
2,514 |
|
|
20,228 |
|
|
10,157 |
|
|
Sales and marketing |
|
849 |
|
|
223 |
|
|
3,233 |
|
|
486 |
|
|
General and administrative |
|
5,416 |
|
|
1,707 |
|
|
13,737 |
|
|
3,547 |
|
|
Depreciation and amortization |
|
1,005 |
|
|
405 |
|
|
2,548 |
|
|
1,400 |
|
|
Total operating costs and expenses |
|
12,485 |
|
|
4,935 |
|
|
40,786 |
|
|
15,733 |
|
|
Loss from operations |
|
(10,837 |
) |
|
(4,935 |
) |
|
(38,687 |
) |
|
(15,733 |
) |
|
Change in fair value of warrant liabilities |
|
(63,332 |
) |
|
- |
|
|
(63,332 |
) |
|
- |
|
|
Offering costs associated with warrants |
|
- |
|
|
- |
|
|
(4,259 |
) |
|
- |
|
|
Other income (expense), net |
|
85 |
|
|
4 |
|
|
92 |
|
|
309 |
|
|
Loss before benefit for income taxes |
|
(74,084 |
) |
|
(4,931 |
) |
|
(106,186 |
) |
|
(15,424 |
) |
|
Benefit for income taxes |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
Net loss |
$ |
(74,084 |
) |
$ |
(4,931 |
) |
$ |
(106,186 |
) |
$ |
(15,424 |
) |
|
Net loss per share attributable to common stockholders |
|||||||||||||
Basic and diluted |
$ |
(0.39 |
) |
$ |
(0.04 |
) |
$ |
(0.77 |
) |
$ |
(0.13 |
) |
|
Weighted average shares used in computing net loss per share attributable to common stockholders |
|||||||||||||
Basic and diluted |
|
192,077,222 |
|
|
116,374,374 |
|
|
137,609,620 |
|
|
115,045,097 |
|
|
|
||||||
Condensed Consolidated Balance Sheets |
||||||
(unaudited) |
||||||
(in thousands) |
||||||
|
||||||
2021 |
2020 |
|||||
Assets |
||||||
Current assets: |
||||||
Cash and cash equivalents |
$ |
399,025 |
|
$ |
36,120 |
|
Short-term investments |
|
123,443 |
|
|
- |
|
Accounts receivable |
|
707 |
|
|
390 |
|
Prepaid expenses and other current assets |
|
6,442 |
|
|
2,069 |
|
Total current assets |
|
529,617 |
|
|
38,579 |
|
Long-term investments |
|
80,110 |
|
|
- |
|
Property and equipment, net |
|
18,870 |
|
|
11,988 |
|
Operating lease right-of-use assets |
|
4,032 |
|
|
4,296 |
|
Intangible assets, net |
|
5,841 |
|
|
2,687 |
|
Other noncurrent assets |
|
3,558 |
|
|
2,928 |
|
Total Assets |
$ |
642,028 |
|
$ |
60,478 |
|
Liabilities and Stockholders' Equity |
||||||
Current liabilities: |
||||||
Accounts payable |
$ |
1,882 |
|
$ |
538 |
|
Accrued expenses |
|
2,647 |
|
|
608 |
|
Current portion of operating lease liabilities |
|
568 |
|
|
495 |
|
Unearned revenue |
|
3,430 |
|
|
240 |
|
Current portion of stock option early exercise liabilities |
|
1,164 |
|
|
- |
|
Total current liabilities |
|
9,691 |
|
|
1,881 |
|
Operating lease liabilities, net of current portion |
|
3,643 |
|
|
3,776 |
|
Unearned revenue, net of current portion |
|
1,533 |
|
|
1,118 |
|
Stock option early exercise liabilities, net of current portion |
|
1,969 |
|
|
- |
|
Warrant liabilities |
|
33,962 |
|
|
- |
|
Total liabilities |
$ |
50,798 |
|
$ |
6,775 |
|
Stockholders' Equity: |
||||||
Common stock |
|
19 |
|
|
3 |
|
Additional paid-in capital |
|
737,150 |
|
|
93,305 |
|
Accumulated deficit |
|
(145,791 |
) |
|
(39,605 |
) |
Accumulated other comprehensive loss |
|
(148 |
) |
|
- |
|
Total stockholders' equity |
|
591,230 |
|
|
53,703 |
|
Total Liabilities and Stockholders' Equity |
$ |
642,028 |
|
$ |
60,478 |
|
|
||||||
Condensed Consolidated Statements of Cash Flows |
||||||
(unaudited) |
||||||
(in thousands) |
||||||
Year Ended |
||||||
2021 |
2020 |
|||||
Cash flows from operating activities: |
||||||
Net loss |
$ |
(106,186 |
) |
$ |
(15,424 |
) |
Adjustments to reconcile net loss to net cash used in operating activities: |
||||||
Depreciation and amortization |
|
2,548 |
|
|
1,400 |
|
Non-cash research and development arrangements |
|
1,335 |
|
|
- |
|
Amortization of customer warrant |
|
528 |
|
|
38 |
|
Offering costs associated with warrants |
|
4,259 |
|
|
- |
|
Stock-based compensation expense |
|
7,748 |
|
|
1,224 |
|
Change in fair value of warrant liabilities |
|
63,332 |
|
|
- |
|
Other, net |
|
101 |
|
|
77 |
|
Changes in operating assets and liabilities: |
||||||
Accounts receivable |
|
(317 |
) |
|
(290 |
) |
Prepaid expenses and other current assets |
|
(3,790 |
) |
|
(699 |
) |
Other noncurrent assets |
|
(1,678 |
) |
|
(11 |
) |
Accounts payable |
|
763 |
|
|
96 |
|
Accrued expenses |
|
1,259 |
|
|
374 |
|
Operating lease liabilities |
|
(44 |
) |
|
(150 |
) |
Unearned revenue |
|
3,605 |
|
|
1,358 |
|
Net cash used in operating activities |
|
(26,537 |
) |
|
(12,007 |
) |
Cash flows from investing activities: |
||||||
Purchases of property and equipment |
|
(7,783 |
) |
|
(10,032 |
) |
Capitalized software development costs |
|
(1,621 |
) |
|
(1,131 |
) |
Purchases of available-for-sale securities |
|
(203,761 |
) |
|
- |
|
Intangible asset acquisition costs |
|
(620 |
) |
|
(513 |
) |
Net cash used in investing activities |
|
(213,785 |
) |
|
(11,676 |
) |
Cash flows from financing activities: |
||||||
Proceeds from stock options exercised |
|
5,457 |
|
|
276 |
|
Repurchase of early exercised stock options |
|
(968 |
) |
|
- |
|
Proceeds from public warrants exercised |
|
26,070 |
|
|
- |
|
Proceeds from merger and PIPE transaction, net of transaction costs |
|
572,668 |
|
|
- |
|
Net cash provided by financing activities |
|
603,227 |
|
|
276 |
|
Net change in cash and cash equivalents |
|
362,905 |
|
|
(23,407 |
) |
Cash and cash equivalents at the beginning of the period |
|
36,120 |
|
|
59,527 |
|
Cash and cash equivalents at the end of the period |
$ |
399,025 |
|
$ |
36,120 |
|
|
|||||||||||||
Reconciliation of Net Loss to Adjusted EBITDA |
|||||||||||||
(unaudited) |
|||||||||||||
(in thousands) |
|||||||||||||
Three Months Ended |
|
Year Ended |
|||||||||||
|
|
|
|||||||||||
2021 |
2020 |
|
2021 |
2020 |
|||||||||
Net loss |
$ |
(74,084 |
) |
$ |
(4,931 |
) |
$ |
(106,186 |
) |
$ |
(15,424 |
) |
|
Interest expense |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
Benefit for income taxes |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
Depreciation and amortization expense |
|
1,005 |
|
|
405 |
|
|
2,548 |
|
|
1,400 |
|
|
Stock-based compensation |
|
1,819 |
|
|
543 |
|
|
7,748 |
|
|
1,224 |
|
|
Change in fair value of assumed warrant liabilities |
|
63,332 |
|
|
- |
|
|
63,332 |
|
|
- |
|
|
Offering cost associated with warrants |
|
- |
|
|
- |
|
|
4,259 |
|
|
- |
|
|
Adjusted EBITDA |
$ |
(7,928 |
) |
$ |
(3,983 |
) |
$ |
(28,299 |
) |
$ |
(12,800 |
) |
View source version on businesswire.com: https://www.businesswire.com/news/home/20220328005800/en/
Media:
ionq@missionnorth.com
Investor:
investors@ionq.com
Source:
FAQ
What are IonQ's total contract bookings for 2021?
What revenue did IonQ report for the fourth quarter of 2021?
What is IonQ's revenue outlook for 2022?
What was IonQ's net loss for 2021?